In conclusion, the current findings reveal that p16, CDH1, RUNX3, MLH1, RASSF1A, p15, APC, GSTP1, Reprimo, or MGMTpromoter methylation is associated with blood samples of patients with GC. The gene discussed is CDKN2A; the disease is gastric cancer.